Navigation Links
One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
Date:9/21/2007

appetite, the amount of food eaten, and body weight. These are not all the side effects with BYETTA. A healthcare provider should be consulted about any side effect that is bothersome or does not go away.

For complete safety profile and other important prescribing considerations, visit http://www.BYETTA.com.

About Amylin and Lilly

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first- in-class medicines for diabetes. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is located in San Diego, California with over 1,700 employees nationwide.

Through a long-standing commitment to diabetes care, Lilly provides patients with breakthrough treatments that enable them to live longer, healthier and fuller lives. Since 1923, Lilly has been the industry leader in pioneering therapies to help health care professionals improve the lives of people with diabetes, and research continues on innovative medicines to address the unmet needs of patients.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Indiana, Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs.

This press release contains forward-looking statements about Amylin and Lilly. Actual results could differ materially from those discussed or implied in this press release due to a number of risks and uncertainties, including the risk that exenatide and the revenu
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...ETON JUNCTION, N.J., Nov. 9 Unwave...cal devices, but recognizing today,s economic clim...uality aesthetic laser systems, introduces the MOS...ced at under $50,000. ,, The MOSAIC CO2 offers...nal technology including scanning and stamping ope...
(Date:11/9/2009)...G, Texas, Nov. 9 RBC L... provider of proprietary nutritional supplements a...amed one of the Top 100 workplaces in the Dallas-F...ning News , the Top 100 Places to Work 2009 compet...eds of small, medium and large firms throughout th...
(Date:11/9/2009)...AM, Mass., Nov. 9 Decision Resourc...ry firms for pharmaceutical and healthcare issues,...r receptor 2 (HER2) targeting therapies -- which i...e/Nippon Kayaku,s Tykerb/Tyverb -- were the highes...ontinued uptake of Herceptin and Tykerb/Tyverb and...
Breaking Medicine Technology:Lutronic(R) Unleashes the New MOSAIC CO2 2RBC Life Sciences Ranked as One of the Top 100 Workplaces in the Dallas-Fort Worth Area 2Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018 2University of Hawaii at Manoa professor published in science journal 9207 1Stem Cell Cord Blood Banking Is Huge Global Business for Hospitals Says CEO of Bio Matrix Scientific Group Inc 12972 1Stem Cell Cord Blood Banking Is Huge Global Business for Hospitals Says CEO of Bio Matrix Scientific Group Inc 12972 2Physical Therapists Say Proper Fit and Use of Walkers and Canes Can Prevent Fall Related Injuries in Elderly 51326 1Physical Therapists Say Proper Fit and Use of Walkers and Canes Can Prevent Fall Related Injuries in Elderly 51326 2
(Date:11/9/2009).... Now Is Time for Senate to Act ,, WASHINGTON,...s a statement by Anna Burger, Chair, Change to Win...of delay, the U.S. House of Representatives had th...egislation to assure every American, regardless of... health care. The House,s action this November is ...
(Date:11/9/2009)... Federal Trade Commission Involvement Need to be A...wswire-USNewswire/ -- Inclusion of a provision in ...962) allowing insurance agents to sell health poli...tive, but other issues remain to be addressed in t...f Professional Insurance Agents (PIA). ,, The l...
(Date:11/9/2009)...udy finds , , MONDAY, Nov. 9 (HealthDay ...trial enlargement, which increases the risk of atr...ows. , Atrial fibrillation is the most common t...artbeat). , Researchers analyzed data on 1,212... followed for 10 years. The study authors conclude...
(Date:11/9/2009)... boost self-esteem, researchers say , , ...en are more likely to have handwriting problems, i...ut autism, researchers say. , The new study inc... participants had autism spectrum disorder, but al...or perceptual reasoning on an IQ test. , The ch...
(Date:11/9/2009)...s are often blamed for the increasing rates of chi...wever finds that 80% of people think that parents ... (PRWEB) November 9, 2009 -- If you th...d Australia’s obesity epidemic, think again....rs. A recent survey commissioned for Fitness.com....
Breaking Medicine News(10 mins):Health News:Statement of Anna Burger, Chair, Change to Win, on U.S. House Vote for Health Care Reform 2Health News:PIA Says Inclusion of Agents in House Healthcare Bill is Positive, But Concerns Remain 2Health News:PIA Says Inclusion of Agents in House Healthcare Bill is Positive, But Concerns Remain 3Health News:Handwriting Skills May Lag in Kids With Autism 2Health News:Fitness.com.au Poll Finds 80% Blame Parents For Our Overweight Kids 2
...rom Boston University School of Medicine have deve...t for lung cancer. The model combines a specific ...l risk factors. These findings currently appear o...han one million deaths worldwide annually. Eighty...
...erican College of Cardiology during,ceremonies at ...in Chicago, CHICAGO, April 1, 2008 Robert O. Bon... Bluhm Cardiovascular Institute,of Northwestern Me...of Cardiology (ACC) as Master of the American Coll...
... Core People Resources,today announced a partners...(CCSC) of Wexford, PA. CCSC provides options in he...benefits for Pennsylvania chamber members through,...hensive human resource,outsourcing that is backed ...
...2008 Abbott,(NYSE: ABT ) will announce its 2008 ...l 16, 2008, before the market opens., The announc...rnings,conference call at 8 a.m. Central time (9 a...will be,available after 11 a.m. Central time., Ab...
...wareness among Hispanic Community as Fewer ...AGO, April 1, 2008 Easter Seals is shining the,sp...h autism, among the,vast array of services the nat... number of children and adults with autism the org...
... Annuity with Guaranteed Withdrawal Benefit, Tur...come for Life for Fortune ...table Life,Insurance Company, which pioneered livi...ion for employees taking,distributions from employ...
Other Medicine News:Health News:Researchers develop new method to test for lung cancer 2Health News:Robert Bonow, MD Honored for Outstanding Service by the American College of Cardiology 2Health News:Robert Bonow, MD Honored for Outstanding Service by the American College of Cardiology 3Health News:Core People Partners to Expand Services 2Health News:Easter Seals Notes April's Autism Awareness Month to Highlight Services Available to Families Living With Autism 2Health News:Easter Seals Notes April's Autism Awareness Month to Highlight Services Available to Families Living With Autism 3Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 2Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 3Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 4Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 5Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 6Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 7
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
Medicine Products: